TipRanks
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market
Want to see GB:DXRX full AI Analyst Report?

Diaceutics (DXRX) Financial Statements

13 Followers

Diaceutics Financial Overview

Diaceutics's market cap is currently £172.63M. The company's EPS TTM is p-0.0032; its P/E ratio is -635.94; Diaceutics is scheduled to report earnings on September 22, 2026, and the estimated EPS forecast is p0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 38.44M£ 32.16M£ 23.70M£ 19.50M£ 13.94M
Gross Profit£ 26.12M£ 28.27M£ 19.71M£ 14.04M£ 10.57M
Operating Income£ 266.00K£ -2.46M£ -3.02M£ 575.00K£ 550.00K
EBITDA£ 6.08M£ 2.77M£ 2.36M£ 3.61M£ 2.35M
Net Income£ 97.00K£ -1.70M£ -1.75M£ 724.00K£ 561.00K
Balance Sheet
Cash & Short-Term Investments£ 7.34M£ 12.74M£ 16.67M£ 19.84M£ 19.68M
Total Assets£ 50.01M£ 48.62M£ 46.34M£ 48.26M£ 45.01M
Total Debt£ 1.15M£ 1.06M£ 1.21M£ 1.33M£ 1.56M
Net Debt£ -6.19M£ -11.68M£ -15.46M£ -18.51M£ -18.11M
Total Liabilities£ 9.53M£ 8.76M£ 5.56M£ 5.74M£ 4.36M
Stockholders' Equity£ 40.48M£ 39.86M£ 40.79M£ 42.51M£ 40.65M
Cash Flow
Free Cash Flow£ 1.43M£ -3.98M£ -3.54M£ 278.00K£ -5.03M
Operating Cash Flow£ 1.50M£ 651.00K£ 1.31M£ 5.15M£ 570.00K
Investing Cash Flow£ -6.45M£ -4.03M£ -4.21M£ -4.87M£ -5.60M
Financing Cash Flow£ -333.00K£ -64.00K£ -239.00K£ -132.00K£ -270.00K
Currency in GBP

Diaceutics Earnings and Revenue History

Diaceutics Debt to Assets

Diaceutics Cash Flow

Diaceutics Forecast EPS vs Actual EPS